Cited by 84Amyotrophic Lateral Sclerosis ResearchDementia and Cognitive Impairment ResearchGenetic Neurodegenerative Diseases

Psychiatric Presentations of C9orf72 Mutation: What Are the Diagnostic Implications for Clinicians?

Open access
Ducharme, Simon, Bajestan, Sepideh, Dickerson, Bradford C., Voon, Valerie·2017·The Journal of Neuropsychiatry and Clinical Neurosciences

Abstract

The C9orf72 mutation was identified as the most frequent genetic cause of frontotemporal dementia (FTD). In light of multiple reports of predominant psychiatric presentations of FTD secondary to C9orf72 mutation, the American Neuropsychiatric Association Committee on Research reviewed all studies on psychiatric aspects of this mutation to identify clinically relevant features for diagnosis. The most common psychiatric presentation is psychosis (21%-56%), with delusions, and/or multimodal hallucinations. Other presentations include late-onset mania and depression with cognitive impairment or catatonia. However, the frequency of C9orf72 mutations is low in typical schizophrenia or bipolar disorders (<0.1%). The authors provide clinical guidance on diagnosis and genetic testing.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/appi.neuropsych.16090168

Cites

94 of 94 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Average diagnostic delay from symptom onset in bvFTD is up to 5-6 years.

    “average diagnostic delay is up to 5-6 years from symptom onset (Woolley et al. , 2011; van Vliet et al. , 2013; Ducharme et al. , 2017).”

    From Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders (2020) · cites this paper as Ducharme et al., 2017

    The Clinical Implications section (page unavailable) says psychiatric symptoms can precede typical bvFTD features by up to 4–5 years, which supports the possibility of a prolonged interval after symptom onset. It does not report an average diagnostic delay of 5–6 years for bvFTD; delayed features are not the same measure as time to diagnosis. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Around 50% of patients with bvFTD receive a prior psychiatric diagnosis.

    “Around 50% of patients with bvFTD receive a prior psychiatric diagnosis”

    From Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders (2020) · cites this paper as Ducharme et al., 2017

    The Major Depressive Disorder discussion says that a psychiatric diagnosis can precede recognition of bvFTD, and Clinical Implications says psychiatric symptoms can precede typical bvFTD features. Neither passage establishes that around 50% of bvFTD patients receive a prior psychiatric diagnosis; the reported percentages concern different outcomes or populations. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Patients with FTD secondary to C9orf72 mutation can present with heterogeneous neuropsychiatric phenotypes (such as late-onset psychosis or mania) without family history, sometimes several years prior to onset of more typical bvFTD features.

    “patients with FTD secondary to the C9orf72 mutation can present with heterogeneous neuropsychiatric phenotypes (such as lateonset psychosis or mania) without family history, sometimes several years prior to onset of more typical bvFTD features (Ducharme et al. , 2017).”
  • C9orf72 repeat expansion carriers can present with psychiatric symptoms and form a diagnostic challenge given their slow progressive course and atypical findings in neuroimaging.

    “C9orf72 repeat expansion carriers can present with psychiatric symptoms and form a diagnostic challenge given their slow progressive course and atypical findings in neuroimaging (see 'Genetic testing' section) (Khan et al. , 2012; Solje et al. , 2015; Ducharme et al. , 2017).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Meisler MH, Grant AE, Jones JM, et al: C9ORF72 expansion in a family with bipolar disorder. Bipolar Disord 2013; 15:326-332
  2. Shinagawa S, Nakajima S, Plitman E, et al: Psychosis in fronto- temporal dementia. J Alzheimers Dis 2014; 42:485-499

Cited by

Sorted by citations

Authors
Ducharme, S., Bajestan, S., Dickerson, B. C., & Voon, V.
Affiliations
Montreal Neurological Institute and Hospital (CA)
Venue
The Journal of Neuropsychiatry and Clinical Neurosciences
Published
2017-07
Volume
29
Issue
3
Pages
195-205
ISSN
  • 0895-0172 (ISSN-L)
  • 1545-7222
OpenAlex
W2594909988
Cited by
84
References
94
Citations by year
2026: 3 · 2025: 11 · 2024: 13 · 2023: 14 · 2022: 6 · 2021: 10 · 2020: 9 · 2019: 11 · 2018: 7
FWCI
0.98
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuropsychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
Medical Research Council (MR/P008747/1)
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Keywords
C9orf72 mutation, frontotemporal dementia, psychiatric presentation, psychosis, delusions, hallucinations, mania, depression, catatonia, genetic testing, differential diagnosis, schizophrenia, bipolar disorder
MeSH terms
C9orf72 Protein, Mental Disorders, Humans, Mutation, Societies, Medical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review